|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berner K, Johannesen TB and Bruland OS:
Clinical epidemiology of low-grade and dedifferentiated
osteosarcoma in Norway during 1975 and 2009. Sarcoma.
2015:9176792015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Allison DC, Carney SC, Ahlmann ER,
Hendifar A, Chawla S, Fedenko A, Angeles C and Menendez LR: A
meta-analysis of osteosarcoma outcomes in the modern medical era.
Sarcoma. 2012:7048722012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21 Suppl 7:vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang J and Zhang W: New molecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ellis BC, Molloy PL and Graham LD: CRNDE:
A long non-coding RNA involved in canceR, neurobiology, and
DEvelopment. Front Genet. 3:2702012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kung JT, Colognori D and Lee JT: Long
noncoding RNAs: Past, present, and future. Genetics. 193:651–669.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu CH, Hsu CL, Lu PC, Lin WC, Juan HF and
Huang HC: Identification of lncRNA functions in lung cancer based
on associated protein-protein interaction modules. Sci Rep.
6:359392016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niu J, Lin Y, Liu P, Yu Y, Su C and Wang
X: Microarray analysis on the lncRNA expression profile in male
hepatocelluar carcinoma patients with chronic hepatitis B virus
infection. Oncotarget. 7:76169–76180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo W, He H, Xiao W, Liu Q, Deng Z, Lu Y,
Wang Q, Zheng Q and Li Y: MALAT1 promotes osteosarcoma development
by targeting TGFA via MIR376A. Oncotarget. 7:54733–54743. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qi D, Li J, Que B, Su J, Li M, Zhang C,
Yang M, Zhou G and Ji W: Long non-coding RNA DBCCR1-003 regulate
the expression of DBCCR1 via DNMT1 in bladder cancer. Cancer Cell
Int. 16:812016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Q, Chen F, Fei Z, Zhao J, Liang Y,
Pan W, Liu X and Zheng D: Genetic variants of lncRNA HOTAIR
contribute to the risk of osteosarcoma. Oncotarget. 7:19928–19934.
2016.PubMed/NCBI
|
|
14
|
Ma B, Li M, Zhang L, Huang M, Lei JB, Fu
GH, Liu CX, Lai QW, Chen QQ and Wang YL: Upregulation of long
non-coding RNA TUG1 correlates with poor prognosis and disease
status in osteosarcoma. Tumour Biol. 37:4445–4455. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Z, Zhao L and Wang Q: Overexpression of
long non-coding RNA HOTTIP increases chemoresistance of
osteosarcoma cell by activating the Wnt/β-catenin pathway. Am J
Transl Res. 8:2385–2393. 2016.PubMed/NCBI
|
|
16
|
Xia WK, Lin QF, Shen D, Liu ZL, Su J and
Mao WD: Clinical implication of long noncoding RNA 91H expression
profile in osteosarcoma patients. Onco Targets Ther. 9:4645–4652.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wei X, Wang C, Ma C, Sun W, Li H and Cai
Z: Long noncoding RNA ANRIL is activated by hypoxia-inducible
factor-1α and promotes osteosarcoma cell invasion and suppresses
cell apoptosis upon hypoxia. Cancer Cell Int. 16:732016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL,
Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding
RNA XIST regulates gastric cancer progression by acting as a
molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin
Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fang J, Sun CC and Gong C: Long noncoding
RNA XIST acts as an oncogene in non-small cell lung cancer by
epigenetically repressing KLF2 expression. Biochem Biophys Res
Commun. 478:811–817. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song P, Ye LF, Zhang C, Peng T and Zhou
XH: Long non-coding RNA XIST exerts oncogenic functions in human
nasopharyngeal carcinoma by targeting miR-34a-5p. Gene. 592:8–14.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schouten PC, Vollebergh MA, Opdam M,
Jonkers M, Loden M, Wesseling J, Hauptmann M and Linn SC: High XIST
and Low 53BP1 expression predict poor outcome after high-dose
alkylating chemotherapy in patients with a BRCA1-like breast
cancer. Mol Cancer Ther. 15:190–198. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang YS, Chang CC, Lee SS, Jou YS and
Shih HM: Xist reduction in breast cancer upregulates AKT
phosphorylation via HDAC3-mediated repression of PHLPP1 expression.
Oncotarget. 7:43256–43266. 2016.PubMed/NCBI
|
|
23
|
Ma L, Zhou Y, Luo X, Gao H, Deng X and
Jiang Y: Long non-coding RNA XIST promotes cell growth and invasion
through regulating miR-497/MACC1 axis in gastric cancer.
Oncotarget. 8:4125–4135. 2017.PubMed/NCBI
|
|
24
|
Li GL, Wu YX, Li YM and Li J: High
expression of long non-coding RNA XIST in osteosarcoma is
associated with cell proliferation and poor prognosis. Eur Rev Med
Pharmacol Sci. 21:2829–2834. 2017.PubMed/NCBI
|
|
25
|
Zhang R and Xia T: Long non-coding RNA
XIST regulates PDCD4 expression by interacting with miR-21-5p and
inhibits osteosarcoma cell growth and metastasis. Int J Oncol.
51:1460–1470. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lv GY, Miao J and Zhang XL: Long
non-coding RNA XIST promotes osteosarcoma progression by targeting
ras-related protein RAP2B via miR-320b. Oncol Res. Apr
12–2017.(Epub ahead of print).
|
|
27
|
Baker EK, Taylor S, Gupte A, Sharp PP,
Walia M, Walsh NC, Zannettino AC, Chalk AM, Burns CJ and Walkley
CR: BET inhibitors induce apoptosis through a MYC independent
mechanism and synergise with CDK inhibitors to kill osteosarcoma
cells. Sci Rep. 5:101202015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meng Q, Ren C, Wang L, Zhao Y and Wang S:
Knockdown of ST6Gal-I inhibits the growth and invasion of
osteosarcoma MG-63 cells. Biomed Pharmacother. 72:172–178. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin DS, Cai LY, Ding J and Gao WY:
Correlation between E-cadherin-regulated cell adhesion and human
osteosarcoma MG-63 cell anoikis. Asian Pac J Cancer Prev.
15:8203–8207. 2014. View Article : Google Scholar : PubMed/NCBI
|
